- Home
- HCKT vs BNTC Comparison
HCKT vs BNTC Comparison
Compare HCKT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCKT | BNTC |
|---|---|---|
| Founded | 1991 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.0M | 411.4M |
| IPO Year | 1998 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HCKT | BNTC |
|---|---|---|
| Price | $13.31 | $10.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $17.00 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 275.5K | 141.5K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.72% | N/A |
| EPS Growth | N/A | ★ 80.94 |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $285,862,000.00 | N/A |
| Revenue This Year | $2.55 | N/A |
| Revenue Next Year | $5.07 | N/A |
| P/E Ratio | $28.07 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.19 | $9.85 |
| 52 Week High | $28.13 | $17.15 |
Technical Indicators
Market Signals| Indicator | HCKT | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 47.24 |
| Support Level | $12.76 | $9.89 |
| Resistance Level | $14.87 | $13.27 |
| Average True Range (ATR) | 0.52 | 0.59 |
| MACD | 0.10 | -0.04 |
| Stochastic Oscillator | 59.12 | 41.99 |
Price Performance
Historical ComparisonAbout HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.